US Stock MarketDetailed Quotes

CCCC C4 Therapeutics

Watchlist

4.550
+0.360+8.59%

Close Nov 27 16:00 ET

4.560
+0.010+0.22%

Post 20:01 ET

321.18MMarket Cap-2660P/E (TTM)

C4 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

38.75%15.36M

350.68%12.01M

-19.15%3.04M

-33.25%20.76M

14.26%3.26M

63.93%11.07M

-80.74%2.66M

-50.89%3.76M

-32.08%31.1M

-85.79%2.85M

Operating revenue

38.75%15.36M

350.68%12.01M

-19.15%3.04M

-33.25%20.76M

14.26%3.26M

63.93%11.07M

-80.74%2.66M

-50.89%3.76M

-32.08%31.1M

-85.79%2.85M

Cost of revenue

Gross profit

Operating expense

12.16%43.61M

-16.86%33.45M

-17.92%32.82M

-0.52%159.79M

-1.12%40.69M

-0.92%38.88M

-2.39%40.23M

2.47%39.99M

25.57%160.63M

16.45%41.15M

Selling and administrative expenses

11.73%11.77M

-5.93%9.7M

-6.00%10.29M

-1.65%42.08M

-1.89%10.3M

9.96%10.53M

4.15%10.31M

-14.63%10.95M

28.67%42.79M

19.51%10.5M

-General and administrative expense

11.73%11.77M

-5.93%9.7M

-6.00%10.29M

-1.65%42.08M

-1.89%10.3M

9.96%10.53M

4.15%10.31M

-14.63%10.95M

28.67%42.79M

19.51%10.5M

Research and development costs

12.32%31.84M

-20.63%23.75M

-22.41%22.53M

-0.11%117.71M

-0.85%30.39M

-4.44%28.35M

-4.46%29.93M

10.83%29.04M

24.48%117.84M

15.45%30.65M

Operating profit

-1.57%-28.24M

42.92%-21.44M

17.79%-29.78M

-7.33%-139.03M

2.26%-37.43M

14.41%-27.81M

-37.19%-37.57M

-15.49%-36.23M

-57.71%-129.53M

-151.02%-38.29M

Net non-operating interest income expense

49.39%3.58M

126.37%3.73M

166.44%3.86M

520.97%8.44M

166.25%2.95M

351.89%2.4M

5,978.57%1.65M

676.89%1.45M

177.30%1.36M

374.94%1.11M

Non-operating interest income

39.66%3.58M

65.89%3.73M

87.83%3.86M

174.46%9.81M

72.62%2.95M

136.35%2.56M

343.87%2.25M

644.20%2.05M

823.77%3.58M

1,156.62%1.71M

Non-operating interest expense

--0

-38.04%1.37M

--0

-69.86%167K

12.36%600K

14.99%606K

3.31%2.22M

11.50%601K

Other net income (expense)

-2.44M

-621K

Special income (charges)

--0

---2.44M

---621K

--0

---621K

--0

-Less：Restructuring and merger&acquisition

--0

--2.44M

----

--0

----

-Less:Other special charges

----

--621K

--0

--621K

----

Income before tax

5.25%-24.67M

50.68%-17.72M

18.46%-28.36M

-2.37%-131.21M

7.28%-34.48M

18.54%-26.03M

-31.04%-35.92M

-9.99%-34.78M

-52.79%-128.18M

-137.48%-37.19M

Income tax

1.28M

277K

Net income

8.77%-24.67M

50.68%-17.72M

18.46%-28.36M

-3.37%-132.49M

6.54%-34.75M

15.40%-27.04M

-31.04%-35.92M

-9.99%-34.78M

-52.79%-128.18M

-137.48%-37.19M

Net income continuous Operations

8.77%-24.67M

50.68%-17.72M

18.46%-28.36M

-3.37%-132.49M

6.54%-34.75M

15.40%-27.04M

-31.04%-35.92M

-9.99%-34.78M

-52.79%-128.18M

-137.48%-37.19M

Minority interest income

Net income attributable to the parent company

8.77%-24.67M

50.68%-17.72M

18.46%-28.36M

-3.37%-132.49M

6.54%-34.75M

15.40%-27.04M

-31.04%-35.92M

-9.99%-34.78M

-52.79%-128.18M

-137.48%-37.19M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

8.77%-24.67M

50.68%-17.72M

18.46%-28.36M

-3.37%-132.49M

6.54%-34.75M

15.40%-27.04M

-31.04%-35.92M

-9.99%-34.78M

-52.79%-128.18M

-137.48%-37.19M

Basic earnings per share

36.36%-0.35

64.38%-0.26

42.25%-0.41

-1.91%-2.67

10.53%-0.68

15.38%-0.55

-30.36%-0.73

-9.23%-0.71

-43.96%-2.62

-145.16%-0.76

Diluted earnings per share

36.36%-0.35

64.38%-0.26

42.25%-0.41

-1.91%-2.67

10.53%-0.68

15.38%-0.55

-30.36%-0.73

-9.23%-0.71

-43.96%-2.62

-145.16%-0.76

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	38.75%15.36M	350.68%12.01M	-19.15%3.04M	-33.25%20.76M	14.26%3.26M	63.93%11.07M	-80.74%2.66M	-50.89%3.76M	-32.08%31.1M	-85.79%2.85M
Operating revenue	38.75%15.36M	350.68%12.01M	-19.15%3.04M	-33.25%20.76M	14.26%3.26M	63.93%11.07M	-80.74%2.66M	-50.89%3.76M	-32.08%31.1M	-85.79%2.85M
Cost of revenue
Gross profit
Operating expense	12.16%43.61M	-16.86%33.45M	-17.92%32.82M	-0.52%159.79M	-1.12%40.69M	-0.92%38.88M	-2.39%40.23M	2.47%39.99M	25.57%160.63M	16.45%41.15M
Selling and administrative expenses	11.73%11.77M	-5.93%9.7M	-6.00%10.29M	-1.65%42.08M	-1.89%10.3M	9.96%10.53M	4.15%10.31M	-14.63%10.95M	28.67%42.79M	19.51%10.5M
-General and administrative expense	11.73%11.77M	-5.93%9.7M	-6.00%10.29M	-1.65%42.08M	-1.89%10.3M	9.96%10.53M	4.15%10.31M	-14.63%10.95M	28.67%42.79M	19.51%10.5M
Research and development costs	12.32%31.84M	-20.63%23.75M	-22.41%22.53M	-0.11%117.71M	-0.85%30.39M	-4.44%28.35M	-4.46%29.93M	10.83%29.04M	24.48%117.84M	15.45%30.65M
Operating profit	-1.57%-28.24M	42.92%-21.44M	17.79%-29.78M	-7.33%-139.03M	2.26%-37.43M	14.41%-27.81M	-37.19%-37.57M	-15.49%-36.23M	-57.71%-129.53M	-151.02%-38.29M
Net non-operating interest income expense	49.39%3.58M	126.37%3.73M	166.44%3.86M	520.97%8.44M	166.25%2.95M	351.89%2.4M	5,978.57%1.65M	676.89%1.45M	177.30%1.36M	374.94%1.11M
Non-operating interest income	39.66%3.58M	65.89%3.73M	87.83%3.86M	174.46%9.81M	72.62%2.95M	136.35%2.56M	343.87%2.25M	644.20%2.05M	823.77%3.58M	1,156.62%1.71M
Non-operating interest expense	--0	--0	--0	-38.04%1.37M	--0	-69.86%167K	12.36%600K	14.99%606K	3.31%2.22M	11.50%601K
Other net income (expense)			-2.44M	-621K	0	-621K
Special income (charges)	--0	--0	---2.44M	---621K	--0	---621K	--0	--0	--0	--0
-Less：Restructuring and merger&acquisition	--0	--0	--2.44M	----	----	--0	--0	--0	----	----
-Less:Other special charges	----	----	----	--621K	--0	--621K	----	----	----	----
Income before tax	5.25%-24.67M	50.68%-17.72M	18.46%-28.36M	-2.37%-131.21M	7.28%-34.48M	18.54%-26.03M	-31.04%-35.92M	-9.99%-34.78M	-52.79%-128.18M	-137.48%-37.19M
Income tax	0	0	0	1.28M	277K	1M	0	0	0	0
Net income	8.77%-24.67M	50.68%-17.72M	18.46%-28.36M	-3.37%-132.49M	6.54%-34.75M	15.40%-27.04M	-31.04%-35.92M	-9.99%-34.78M	-52.79%-128.18M	-137.48%-37.19M
Net income continuous Operations	8.77%-24.67M	50.68%-17.72M	18.46%-28.36M	-3.37%-132.49M	6.54%-34.75M	15.40%-27.04M	-31.04%-35.92M	-9.99%-34.78M	-52.79%-128.18M	-137.48%-37.19M
Minority interest income
Net income attributable to the parent company	8.77%-24.67M	50.68%-17.72M	18.46%-28.36M	-3.37%-132.49M	6.54%-34.75M	15.40%-27.04M	-31.04%-35.92M	-9.99%-34.78M	-52.79%-128.18M	-137.48%-37.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	8.77%-24.67M	50.68%-17.72M	18.46%-28.36M	-3.37%-132.49M	6.54%-34.75M	15.40%-27.04M	-31.04%-35.92M	-9.99%-34.78M	-52.79%-128.18M	-137.48%-37.19M
Basic earnings per share	36.36%-0.35	64.38%-0.26	42.25%-0.41	-1.91%-2.67	10.53%-0.68	15.38%-0.55	-30.36%-0.73	-9.23%-0.71	-43.96%-2.62	-145.16%-0.76
Diluted earnings per share	36.36%-0.35	64.38%-0.26	42.25%-0.41	-1.91%-2.67	10.53%-0.68	15.38%-0.55	-30.36%-0.73	-9.23%-0.71	-43.96%-2.62	-145.16%-0.76
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data